PORTON BIOPHARMA LIMITED
Get an alert when PORTON BIOPHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-06-30 (in 1y)
Last filed for 2025-09-30
Confirmation statement due
2026-12-11 (in 7mo)
Last made up 2025-11-27
Watchouts
None on the register
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- WR Partners
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Group is funded using its own cash reserves and had cash at bank and in hand of £44.1 million as at 30 September 2025, a decrease of £3.2 million since 30 September 2024. ... In addition, the Group benefits from an indemnity from UKHSA that supports the business as a going concern for 12 months from the signing of these financial statements until 31 December 2028 at the earliest. As such, the Company's Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and therefore they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Group structure
- PORTON BIOPHARMA LIMITED · parent
- Porton Biopharma Limited 100%
Significant events
- “As a result of the decision to cease production, a Group wide consultation process was launched in February 2025 leading to a significant reduction in the size of the workforce. ... As at 20 December 2025 the Group's workforce had fallen to 28 employees as compared with 109 as at 30 September 2025.”
- “The outcome of this review was to recommend to the shareholders that production of ERW cease in early 2025. In February 2025, it was determined that the Group had sufficient ERW stock to meet the projected demand in the existing markets in which ERW is sold for the foreseeable future. This was deemed to be a reasonable and corporately responsible period to enable the markets currently served by ERW to identify an alternative product for patients beyond 2027.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BURN, Andrew James Sebastian | Director | 2025-01-13 | May 1974 | British |
| JONES, Alex | Director | 2025-01-13 | Apr 1976 | British |
| SMITH, Richard Paul | Director | 2025-02-10 | Nov 1986 | British |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MACKIE, Nigel Richard Mowbray | Secretary | 2015-08-18 | 2021-03-31 |
| ANDREWS, Martin | Director | 2020-06-01 | 2024-05-08 |
| AUSTIN, Michael | Director | 2021-11-23 | 2024-12-04 |
| BRODIE, Michael | Director | 2014-11-27 | 2019-08-30 |
| BROOKSBY, Nigel Stanley | Director | 2016-06-01 | 2019-06-30 |
| CLARE, Barry | Director | 2018-12-03 | 2022-08-05 |
| GLEAVE, Donald Richard | Director | 2014-11-27 | 2020-07-14 |
| HARRISON, Michael James | Director | 2017-05-08 | 2019-02-15 |
| HINDLE, Martin | Director | 2015-03-31 | 2019-10-31 |
| HINTON, Roger James | Director | 2015-03-12 | 2020-12-07 |
| MILLS, Patrick Mark Herbert | Director | 2015-10-07 | 2017-01-31 |
| MUIR, Ian Stuart | Director | 2021-01-18 | 2021-11-16 |
| PRITCHARD, Bruce Philip | Director | 2020-06-01 | 2024-05-03 |
| SHEPHERD, Donald Anthony | Director | 2019-11-12 | 2025-02-10 |
| WEST, Martin | Director | 2022-08-08 | 2025-08-26 |
| WILSON, Rebecca | Director | 2020-02-11 | 2025-01-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Secretary Of State For Health | Legal person | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 76 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-10-07 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-27 | AA | accounts | Accounts with accounts type group | |
| 2025-12-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-04 | CH01 | officers | Change person director company with change date | |
| 2025-10-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-09-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-03 | AA | accounts | Accounts with accounts type group | |
| 2025-02-10 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-24 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-13 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-20 | AA01 | accounts | Change account reference date company current extended | |
| 2024-05-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-18 | AA | accounts | Accounts with accounts type group | |
| 2023-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-23 | AA | accounts | Accounts with accounts type group | |
| 2022-12-08 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one